Breaking News, Collaborations & Alliances

Avid Partners with California Institute for Regenerative Medicine

CIRM-funded programs to receive access to Avid’s suite of world-class CGT CDMO services.

Avid Bioservices, a biologics contract development and manufacturing organization (CDMO), entered into a new partnership with the California Institute for Regenerative Medicine (CIRM) Industry Resource Partner Program. The collaboration is designed to support the advancement of manufacturing of adeno-associated adenovirus (AAV), as well as other cell and gene therapy (CGT) programs within the state of California. With $5.5 billion in funding from the state of California, CIRM is accelerating wor...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters